Allergy Asthma Proc. 2019 Nov 1;40(6):380-384. doi: 10.2500/aap.2019.40.4252.
Rhinosinusitis is defined as inflammation of one or more of the paranasal sinuses and affects approximately 12% of the population. Acute rhinosinusitis is defined as symptoms that last < 12 weeks, and chronic rhinosinusitis (CRS) is defined as symptoms that last > 12 weeks. CRS is divided into three groups: CRS with nasal polyps (CRSwNP), CRS without nasal polyps (CRSsNP), and allergic fungal rhinosinusitis. Nasal polyps are inflammatory outgrowths of paranasal sinus mucosa caused by chronic mucosal inflammation and are present in 20% of patients with CRS. Nasal polyps typically present with nasal congestion, nasal obstruction, and anosmia or hyposmia, and occur more frequently in patients with persistent asthma, aspirin-exacerbated respiratory disease (AERD), CRS, and cystic fibrosis. The sinus cavities are lined with pseudostratified ciliated columnar epithelial cells interspersed with mucous goblet cells. Cilia continuously sweep the mucous toward the ostial openings and are important in maintaining the proper environment of the sinus cavities. The frontal, maxillary, and anterior ethmoid sinuses drain into the ostiomeatal unit of the middle meatus. The posterior ethmoid sinuses and superior sphenoid sinuses drain into the sphenoethmoid recess of the superior meatus. Most acute sinus infections are caused by viruses, and, therefore, it is not surprising that the majority of patients improve within 2 weeks without antibiotic treatment. A bacterial infection should be considered if symptoms worsen or fail to improve within 7-10 days. Combining an intranasal corticosteroid with an antibiotic reduces symptoms more effectively than antibiotics alone. Topical nasal steroids are the treatment of choice for nasal polyps. They significantly decrease polyp size, nasal congestion, and rhinorrhea, and increase nasal airflow. Short courses of oral steroids may be needed to reduce polyp size, followed by maintenance therapy with topical steroids. Surgery is reserved for patients in which polyps cause severe obstruction or recurrent sinusitis and for patients for whom medical therapy has failed. Aspirin desensitization may decrease the requirement for polypectomies and sinus surgery in patients with AERD.
鼻窦炎被定义为一个或多个鼻窦的炎症,影响约 12%的人口。急性鼻窦炎的定义是症状持续<12 周,而慢性鼻窦炎(CRS)的定义是症状持续>12 周。CRS 分为三组:伴有鼻息肉的 CRS(CRSwNP)、不伴鼻息肉的 CRS(CRSsNP)和变应性真菌性鼻窦炎。鼻息肉是由慢性黏膜炎症引起的鼻窦黏膜炎性赘生物,存在于 20%的 CRS 患者中。鼻息肉通常表现为鼻塞、鼻阻塞和嗅觉减退或丧失,在持续性哮喘、阿司匹林加重的呼吸道疾病(AERD)、CRS 和囊性纤维化患者中更为常见。鼻窦腔衬有假复层纤毛柱状上皮细胞,间有黏液杯状细胞。纤毛不断地将黏液扫向口部开口,这对于维持鼻窦腔的正常环境非常重要。额窦、上颌窦和前筛窦流入中鼻道的口道复合体。后筛窦和上蝶窦流入上鼻道的蝶筛隐窝。大多数急性鼻窦感染是由病毒引起的,因此,大多数患者在没有抗生素治疗的情况下,在 2 周内自行改善并不奇怪。如果症状在 7-10 天内恶化或没有改善,应考虑细菌感染。与单独使用抗生素相比,将鼻内皮质类固醇与抗生素联合使用可以更有效地缓解症状。局部鼻腔类固醇是鼻息肉的首选治疗方法。它们显著减少息肉大小、鼻塞和鼻漏,并增加鼻气流。短期口服类固醇可能需要减少息肉大小,然后用局部类固醇维持治疗。手术保留用于息肉引起严重阻塞或复发性鼻窦炎的患者,以及药物治疗失败的患者。阿司匹林脱敏可能减少 AERD 患者息肉切除术和鼻窦手术的需要。